期刊文献+

HPV16 CTL表位E749-57以HSP110为分子伴侣的免疫原性研究 被引量:1

Immunogenicity of the immunodominant cytotoxic T lymphocyte epitope E749-57 in HPV16 oncoprotein E7 chaperoned by HSP110
原文传递
导出
摘要 目的 探讨以mHSP110为分子伴侣的HPV16 CTL表位E749-57的免疫原性.方法 将mHSP110基因克隆、原核表达和纯化,SDS-PAGE和Western blot鉴定.在热休克状态与E749-57结合形成复合物,高压液相色谱(HPLC)鉴定其结合程度.用mHSP1 10-E749-57复合物免疫小鼠,IFN-γ胞内染色、MTT法检测小鼠脾细胞中特异CTL.结果 克隆mHSP110片段经DNA序列测定与基因库中其CDS一致,长度为2577 bp 经SDS-PAGE和Western印迹证实mHSP110表达、纯化成功,HPLC分析E749-57能够与mHSP110形成复合物.复合物免疫小鼠的脾淋巴细胞中CD8+IFN-γ+T细胞的频率、脾淋巴细胞增殖活性明显高于E749-57组、HSP110组和PBS组.复合物免疫小鼠可明显抑制TC-1肿瘤的生长.结论 mHSP110-E749-57复合物能诱导产生特异性CTL并产生抗肿瘤效应. Objective To investigate the immunogenicity of immunodominant cytotoxic T lymphocyte epitope E749-57 of human papilloma virus (HPV) 16 oncoprotein E7 chaperoned by heat shock protein (HSP)110. Methods Mouse HSP110 gene was cloned into prokaryotic expression vector pQE-80L for the expression of HSP110 protein, which was purified using Ni-NTA column. SDS-PAGE and Western-blot were conducted to confirm the purified mHSP110 protein, which was subsequently incubated with E749-57 peptide under heat shock condition, and high-performance liquid chromatography (HPLC) was used to evaluate the binding efficiency of the recombinant protein and E749-57 peptide. Twenty mice were divided into 4 groups to be immunized with mHSP110 protein, E749-57 peptide, mHSP110-E749-57 complex and phosphate buffered saline (PBS),respectively. Two weeks after the last immunization, spleen cells were collected from the immunized mice and divided into 2 parts: one were stimulated by E749-57 peptide followed by the detection of CD8+ INF-γ+ T cells with flow cytometry the other one were subjected to MTT analysis for the estimation of cell proliferation. The mHSP110-E749-57 complex was also used to immunize TC-1 tumor bearing mice to observe its anti-tumor effect.Results The full-length 2577 bp-sized mHSP110 gene was amplified from mouse liver cDNA and cloned into pQE-80L vector. Direct sequencing confirmed the correctness of the cloning. SDS-PAGE and Western-blot demonstrated the successful purification of mHSP110. HPLC assay showed that the purified mHSP110 protein could bind with E749-57 to form a relatively stable protein complex. The percentage of IFN-γ+ CD8+ T cells in and proliferation index of spleen cells from the complex-immunized mice were statistically higher than those from the other 3 groups of mice. Moreover, the complex could obviously inhibit the growth of TC-1 tumor in mice. Conclusion The mHSP110-E749-57 complex could enhance the generation of specific cytotoxic T lymphocytes and exert anti-tumor effects in mice.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2010年第5期346-349,共4页 Chinese Journal of Dermatology
基金 国家自然科学基金(30972800、30500537、60873103)
关键词 人乳头状瘤病毒16 表位 T淋巴细胞 HSP110热休克蛋白质类 Human, papillomavirus 16 Epitopes T-lymphocytes HSP110 heat-shock proteins
  • 相关文献

参考文献8

  • 1Manjili MH,Henderson R,Wang XY,et al.Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.Cancer Res,2002,62(6):1737-1742.
  • 2Wang XY,Chen X,Manjili MH,et al.Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.Cancer Res,2003,63(10):2553-2560.
  • 3Kim HL,Sun X,Subjeck JR,et al.Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110.Cancer Immunol Immunother,2007,56 (7):1097-1105.
  • 4Román E,Moreno C.Synthetic peptides non-covalently bound to bacterial hsp 70 elicit peptide-specific T-cell responses in vivo.Immunology,1996,88(4):487-492.
  • 5Li Z.In vitro reconstitution of heat shock protein-peptide complexes for generating peptide-specific vaccines against cancers and infectious diseases.Methods,2004,32(1):25-28.
  • 6Blachere NE,Li Z,Chandawarkar RY,et al.Heat shock proteinpeptide complexes,reconstituted in vitro,elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.J Exp Med,1997,186(8):1315-1322.
  • 7尹锐,郝飞,郝进,钟白玉,曹红卫.HIV Tat_(49-57)增强人乳头瘤病毒16E7细胞毒性T细胞表位穿膜效应研究[J].中华皮肤科杂志,2006,39(5):285-288. 被引量:5
  • 8徐云升,郝飞,郝进,杨希川,杨卫兵.人乳头瘤病毒16E7_(49-57)的分子修饰与鉴定[J].中华皮肤科杂志,2005,38(6):371-373. 被引量:4

二级参考文献14

  • 1尹锐,郝飞.穿膜肽HIV Tat蛋白的研究进展[J].免疫学杂志,2005,21(B06):77-81. 被引量:6
  • 2尹锐,郝飞,郝进,杨希川.人乳头瘤病毒16E7限制性细胞毒性T淋巴细胞表位的穿膜肽疫苗设计及体外免疫学研究[J].临床皮肤科杂志,2005,34(12):807-809. 被引量:6
  • 3Cassetti MC, McElhiney SP, Shahabi V, et al. Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes. Vaccine, 2004, 22: 520-527.
  • 4Angeline M, Merle E, Moroianu J. The E7 oncoprotein of high-risk human papillomavirus type 16 enters the nucleus via a nonclassical Ran-dependent pathway. Virology, 2003, 317: 13-23.
  • 5Schaeffer A J, Nguyen M, Liem A, et al. E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice. Cancer Res, 2004, 64: 538-546.
  • 6Lindgren M,Hallbrink M,Prochiantz A,et al.Cell-penetrating peptides.Trends Pharmacol Sci,2000,21:99-103.
  • 7Vives E,Brodin P,Lebleu B.A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.J Biol Chem,1997,272:16010-16017.
  • 8Rosenberg SA.Progress in human tumour immunology and immunotherapy.Nature,2001,411 (6835):380-384
  • 9Bullock TN,Colella TA,Engelhard VH.The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice.J Immunol,2000,164:2354-2361.
  • 10Kurts C,Miller JF,Subramaniam RM,et al.Major histocompatibility complex class Ⅰ-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction.J Exp Med,1998,188:409-414.

共引文献7

同被引文献8

  • 1Ren F, Xu Y. Mao L, el al. Heal shock protein 110 improves the anlitumor effects of tile eyloloxie T lymphocyte epilope E7 (49- 57 ) in mice. Cancer Biol Ther. 2010. 9(2): 134-141.
  • 2Cahleira Jdo C. Medfimt A. Kines RC, et al. lmmunogenic display of diverse peptides, including a broadly cross-type neutraliziog human papillomavirus 1,2 epilope, on virus-like particles of the RNA bacteriophage PP7. Vaccine. 2010. 28(27): 4384-4393.
  • 3Cento V, Ciecozzi M, Ronga 14. et al. Genetie diversity of human papillomavirus type 16 E6, ET. and L1 genes in Italian women with different grades of cervical lesions. J Med Virol, 2009, 81 (9): 1627-1634.
  • 4Corvino V, Marchese E, Zarkovic N, et al Distribution and time- course of 4-hydmxynonenal. heat shock protein 110/105 family members and cyelooxygenase-2 expression in the hippocampus of rat during trimethyltin-induced neurodegeneration. Neunochem Res, 2011, 36(8): 1490-1500.
  • 5Choi DH, Woo JK, Choi Y. et al. A novel chimeric DNAvaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by filsion of Muein 1 to a heat shnek protein 70 gene. Mol Med Report, 201 1, 4( 5 ): 885-890.
  • 6Lambeck AJ. Nijmau HW, Hoogehoom BN. et al. Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimens. Vaccine. 2010, 28( 26 ): 4275-4282.
  • 7徐云升,欧荣英,张文淼,张学奇,李秉煦,蔡剑峰.HPV16E711-20配体抗肿瘤免疫的作用[J].中国皮肤性病学杂志,2011,25(3):171-173. 被引量:1
  • 8缪飞,王秀丽,王宏伟,丁蕙琳,吕婷,张玲琳.稳定表达人乳头瘤病毒16E7蛋白HaCaT细胞株的建立[J].中华皮肤科杂志,2011,44(5):310-313. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部